InspireMD (NYSE:NSPR) logged a provisional win yesterday in a battle over nearly $3 million it allegedly owes in finder’s fees related to some $24 million in financing for the cardiac device maker. Private equity shop Microbanc and managing member Todd Spenla sued InspireMD in May 2016, alleging that the company breached a contract stipulating a 9% finder’s […]
Wall Street Beat
Medtronic touts Solitaire stent retriever data
Medtronic (NYSE:MDT) yesterday touted data presented at the International Stroke Conference on its Solitaire stent retriever from 4 studies. The Solitaire stent retriever uses a micro-sized catheter to access arteries in the brain, restoring blood flow and removing blood clots that cause acute ischemic stroke. The Stratis AIS study evaluated the impact of treatment delays and […]
Intersect ENT wins FDA nod for Propel Contour steroid-releasing implant
Intersect ENT(NSDQ:XENT) said today that it won FDA approval for its Propel Contour steroid-releasing implant for the treatment of chronic sinusitis in the frontal and maxillary sinsuses. The Menlo Park, Calif.-based company’s portfolio of steroid-releasing implants are used in patients undergoing ethmoid, frontal or maxillary surgeries to treat chronic sinusitis. Get the full story at […]
LivaNova to exit London Stock Exchange
LivaNova (NSDQ:LIVN) said today that it plans to stop trading on the London Stock Exchange, citing the low volume of trading in its shares there. Formed by the $3 billion merger of Sorin Group and Cyberonics, LivaNova said it plans to stop trading on the LSE as of the close of trading there April 4. LIVN shares will still […]
GlaxoSmithKline, Innoviva tout data for Relvar Ellipta inhaled drug combo
GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) touted data today from a non-inferiority lung function study evaluating its inhaled, once-daily corticosteroid/long-acting beta2 agonist combination therapy in patients with asthma. The study showed that patients with well-controlled asthma could switch from the twice-daily Seretide Accuhaler to the companies’ once-daily Relvar Ellipta therapy without compromising lung function. Get the full story […]
Seventh Sense Biosystems wins FDA nod for blood collection device
Seventh Sense Biosystems said today its Tap blood collection device won FDA 510(k) clearance. The company’s push-botton device collects capillary blood for hemoglobin A1C testing without the use of large needles. The Tap device is designed to be placed on the upper arm and blood collection, which takes 2 to 3 minutes, begins with a […]
Amgen wins marketing authorization for Repatha single-dose delivery option
Amgen (NSDQ:AMGN) said today that the European Commission granted a change to the marketing authorization of its Repatha device, approving a single-dose delivery option. The pre-filled cartridge mini-doser is a hands-free device that is designed to provide 420 mg of Repatha (evolocumab) in a single injection for patients with cardiovascular disease. The company touted its […]
Penumbra: Stroke study shows aspiration system equal to stent retrievers
Penumbra (NYSE:PEN) touted data from the Aster trial evaluating its aspiration system compared to a stent retriever as a first-line thrombectomy approach for acute ischemic stroke. The data showed that the company’s direct aspiration, first-pass technique (Adapt) compared favorably with a stent retriever – 85.4% of patients treated with Penumbra’s aspiration system met the study’s […]
Meril’s bioresorbable, drug-eluting vascular scaffold
Meril Life Sciences has developed a drug-eluting, bioresorbable vascular scaffold that the body can slowly degrade and wash away. The company’s MeRes100 is made of biodegradable polymers, PLLA and PDLLA. Sirolimus, a commonly-used immunosuppressant found in drug eluting stents, is embedded in the scaffold’s coating. The company designed the struts of the device to be just […]
Merit Medical sees 52-week high on Q4, 2016 beats
Merit Medical (NSDQ:MMSI) posted 4th-quarter results today that beat the consensus forecast on Wall Street, sending share prices to a new 52-week high. The South Jordan, Utah-based medical device company said profits were up 17.1% to $7.5 million, or 17¢ per share, on sales of $157.7 million for the 3 months ended Dec. 31, for top-line growth of 14.0% […]
BrainStorm seeks early Health Canada nod for NurOwn treatment
Brainstorm Cell Therapeutics (NSDQ:BCLI) is reportedly seeking early regulatory approval in Canada for its NurOwn stem cell treatment for patients with ALS. The company told Reuters this week that it has inked an agreement with a Canadian non-profit organization, CCRM, that helps to support the development of regenerative medicine. The organization plans to help BrainStorm meet Canadian regulatory requirements […]